Tradestie Institutional Equity Comparison Engine

MBAI vs NDRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NDRA Overall Edge

NDRA Captures Institutional Edge (2โ€“0 Pillars ยท 8โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ENDRA Life Sciences Inc. Common Stock (NDRA) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, MBAI trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus NDRA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, MBAI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NDRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MBAI N/M vs NDRA N/M Fwd P/E
Growth & Margin Winner NDRA
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner NDRA
1Y +11.2% vs -32.7% ยท 52W Pos 12% vs 37%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MBAI US Equity
MBAI
Institutional Equity
$2.08
+1.22% 1D
Market Cap N/A
1M Return -24.36%
1Y Return +11.23%
Forward P/E N/M
Unified AI Score
42.5 / 100 HOLD
Tech 26.0 Fund 47.0 Flow 50.0 Mom 60.0
NDRA NASDAQ
ENDRA Life Sciences Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.42
+0.23% 1D
Market Cap $6.6M
1M Return -6.75%
1Y Return -32.72%
Forward P/E N/M
Unified AI Score
44.7 / 100 HOLD
Tech 35.0 Fund 46.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MBAI +11.23% NDRA -32.72% Spread: +36.44 pp (MBAI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MBAI TTM Op. Margin: N/A NDRA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MBAI vs NDRA. Trailing 12-month operating profitability (MBAI N/A vs NDRA 0.0%) and valuation multiples (MBAI N/M vs NDRA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MBAI (0) vs NDRA (8)
Institutional Metric MBAI NDRA Criterion Row Winner
Market Capitalization Scale N/A $6.6M Larger Scale NDRA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +0.0% Higher Growth NDRA
Operating Margin (TTM) Profitability N/A 0.0% Higher Margin NDRA
Net Profit Margin Profitability N/A 0.0% Higher Margin NDRA
Return on Equity (ROE) Capital Efficiency N/A -152.0% Higher ROE NDRA
52-Week Range Position Momentum 12% ($1โ€“$10) 37% ($3โ€“$7) Stronger Trend NDRA
Beta / 30D Volatility Risk Regime 3.78ฮฒ ยท 129% Vol 0.71ฮฒ ยท 48% Vol Lower Realized Risk NDRA
Unified Institutional Score Composite Signal 42.5 / 100 (HOLD) 44.7 / 100 (HOLD) Higher Composite NDRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MBAI vs NDRA Buy Guide
MBAI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MBAI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NDRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NDRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MBAI nor NDRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.